A detailed history of Rothschild & CO Asset Management Us Inc. transactions in Amgen Inc stock. As of the latest transaction made, Rothschild & CO Asset Management Us Inc. holds 1,960 shares of AMGN stock, worth $555,875. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,960
Previous 2,010 2.49%
Holding current value
$555,875
Previous $453,000 13.47%
% of portfolio
0.01%
Previous 0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$229.03 - $291.01 $11,451 - $14,550
-50 Reduced 2.49%
1,960 $514,000
Q1 2022

May 13, 2022

SELL
$219.27 - $242.57 $2,192 - $2,425
-10 Reduced 0.5%
2,010 $486,000
Q3 2021

Nov 09, 2021

SELL
$212.27 - $248.7 $16,981 - $19,896
-80 Reduced 3.81%
2,020 $430,000
Q1 2021

May 14, 2021

SELL
$221.91 - $258.6 $6,657 - $7,758
-30 Reduced 1.41%
2,100 $523,000
Q3 2020

Nov 09, 2020

BUY
$234.65 - $260.95 $39,890 - $44,361
170 Added 8.67%
2,130 $541,000
Q2 2020

Aug 10, 2020

BUY
$197.81 - $242.74 $71,211 - $87,386
360 Added 22.5%
1,960 $462,000
Q4 2019

Feb 12, 2020

SELL
$189.21 - $243.2 $9,460 - $12,160
-50 Reduced 3.03%
1,600 $386,000
Q3 2019

Nov 08, 2019

SELL
$174.11 - $208.62 $8,705 - $10,431
-50 Reduced 2.94%
1,650 $319,000
Q1 2019

May 08, 2019

SELL
$180.87 - $203.88 $398,999 - $449,759
-2,206 Reduced 56.48%
1,700 $323,000
Q4 2018

Feb 05, 2019

SELL
$178.4 - $208.25 $1,427 - $1,666
-8 Reduced 0.2%
3,906 $760,000
Q3 2018

Nov 13, 2018

SELL
$185.29 - $208.89 $18,714 - $21,097
-101 Reduced 2.52%
3,914 $811,000
Q2 2018

Aug 07, 2018

SELL
$166.05 - $186.51 $115,902 - $130,183
-698 Reduced 14.81%
4,015 $741,000
Q1 2018

May 08, 2018

SELL
$169.43 - $198.0 $23.7 Million - $27.7 Million
-139,904 Reduced 96.74%
4,713 $803,000
Q4 2017

Feb 12, 2018

SELL
$168.79 - $188.59 $281,035 - $314,002
-1,665 Reduced 1.14%
144,617 $25.1 Million
Q3 2017

Nov 08, 2017

BUY
$167.29 - $191.0 $24.5 Million - $27.9 Million
146,282
146,282 $27.3 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $152B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Rothschild & CO Asset Management Us Inc. Portfolio

Follow Rothschild & CO Asset Management Us Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild & CO Asset Management Us Inc., based on Form 13F filings with the SEC.

News

Stay updated on Rothschild & CO Asset Management Us Inc. with notifications on news.